Abstract
Introduction: Sympathomimetic (α-adrenergic) drugs are mainly used because of their vasoconstrictor properties, for nasal congestion, or as mydriatics. Although sympathomimetic drugs are used often, allergic reactions are rare, especially when the drugs are administered systemically. Cross-reactivity may exist among catecholamine derivatives, although reported data on this are contradictory. In this study, we investigate if there is cross-reactivity in patch tests among these drugs.
Material and methods: Patch tests with 10% phenylephrine and 10% pseudoephedrine in petrolatum, and 10% and 20% ephedrine, 10% phenylpropanolamine, 5% fepradinol, 1% methoxamine, and 10% oxymetazoline, all administered in dimethyl sulfoxide (DMSO), were carried out in 14 patients with a history of allergy to any of these drugs. DMSO was used as the negative control.
Results: All patients except one (patient number five) showed positive patch-test reactions to at least two different drugs. Nine patients (64.3%) were cross-sensitized to three or more different drugs, and 57.1% of patients were sensitized to four or more sympathomimetic drugs. Patients who experienced generalized rashes caused by orally administered pseudoephedrine had a stronger response and more cross-reactivity with other sympathomimetic drugs in patch tests than those who experienced local contact dermatitis.
Conclusions: We conclude that there is cross-reactivity among the different sympathomimetic drugs tested, especially if the drug is administered systemically.
Similar content being viewed by others
References
Vervloet D, Pradal M, Castelain M, editors. Drug allergy. 3rd ed. Uppsala: Pharmacia & Upjohn, 1999: 237–8
The Royal Pharmaceutical Society. Sympathomimetics. In: Reynolds JEF, editor. Martindale: the extra pharmacopoeia. 31st ed. London: The Royal Pharmaceutical Society, 1996: 1563–95
Villarreal O. Reliability of diagnostic tests for contact allergy to mydriatic eye drops. Contact Dermatitis 1998; 38: 150–4
Thomas P, Rueff F, Przybilla B. Allergic contact dermatitis from phenylephrine in a phlebological ointment. Contact Dermatitis 1995; 32: 249–50
Mancuso G, Reggiani M, Staffa M. Long-lasting allergic patch test reaction to phenylephrine. Contact Dermatitis 1997; 36: 110–1
Marcos ML, Garcés MM, Alonso L, et al. Occupational allergic contact dermatitis from homatropine and phenylephrine eye drops. Contact Dermatitis 1997; 37: 189
Añibarro B, Barranco P, Ojeda JA. Allergic contact blepharoconjunctivitis caused by phenylephrine eye drops. Contact Dermatitis 1991; 25: 323–4
Quirce S, Compaired JA, Fernández M, et al. Hypersensitivity to phenylephrine in topical ocular administration. Med Clin (Barc) 1991; 96: 317–8
Almeida L, Ortega N, Dumpierrez AG, et al. Conjunctival allergic contact hypersensitivity. Allergy 2001; 56: 785
Moreno-Ancillo A, Muñoz-Robles ML, Cabañas R, et al. Allergic contact reactions due to phenylephrine hydrochloride in eye drops. Ann Allegy Asthma Immunol 1997; 78: 569–72
Thomas P, Rueff F, Przybilla B. Severe allergic contact blepharoconjunctivitis from phenylephrine in eye drops, with corresponding T-cell hyper-responsiveness in vitro. Contact Dermatitis 1998; 38: 41–2
Gonzalo-Garijo MA, Pérez-Calderón R, De Argila D, et al. Erythrodermia to pseudoephedrine in a patient with contact allergy to phenylephrine. Allergol Immunopathol (Madr) 2002; 30: 239–42
Venturini M, Lezaun A, Abos T, et al. Immediate hypersensitivity due to pseudoephedrine. Allergy 2002; 57: 52–3
Rochina A, Burchés E, Morales C, et al. Adverse reaction to pseudoephedrine. J Invest Allergol Clin Immunol 1995; 5: 235–6
Moreno-Escobosa MC, Cuesta J, Figueredo E, et al. Sensibilización por pseudoefedrina [abstract]. Rev Esp Alergol Inmunol Clin 1998; 13: 213
Díaz-Jara M, Tornero P, Barrio M, et al. Pigmented purpuric dermatosis due to pseudoephedrine. Contact Dermatitis 2002; 46: 300–1
Tomb RR, Lepoittevin JP, Espinassouze F, et al. Systemic contact dermatitis from pseudoephedrine. Contact Dermatitis 1991; 24: 86–8
Audicana M, Echechipia S, Fernández E, et al. Contact dermatitis from phenylephrine. Am J Contact Dermatitis 1993; 4: 225–8
Sánchez TS, Sánchez-Pérez J, Aragues M, et al. Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test. Contact Dermatitis 2000; 42 (5): 312–3
Buzo-Sánchez G, Martín-Muñoz MR, Navarro-Pulido AM, et al. Stereoisomeric cutaneous hypersensitivity. Ann Pharmacother 1997; 31: 1091
Aranzabal A, De Barrio M, Rodríguez V, et al. Allergic contact dermatitis from fepradinol. Contact Dermatitis 1994; 31: 121
Ortíz-Frutos FJ, Hergueta JP, Quintana I, et al. Allergic contact dermatitis from fepradinol: report of 4 cases and review of the literature. Contact Dermatitis 1994; 31: 193–5
Izu R, Aguirre B, Goday JJ, et al. Allergic contact dermatitis from fepradinol. Contact Dermatitis 1992; 27: 266–7
Goday JJ, Yanguas I, Ilardia R, et al. Subacute contact dermatitis from fepradinol. Contact Dermatitis 1993; 29: 160
Acknowledgments
We would like to thank Dr José Manuel Zubeldia Ortuño for helping with the statistical study. The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barranco, R., Rodríguez, A., de Barrio, M. et al. Sympathomimetic Drug Allergy. Am J Clin Dermatol 5, 351–355 (2004). https://doi.org/10.2165/00128071-200405050-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200405050-00008